Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma

No Thumbnail Available

Authors

Buhl, R.
Soler, M.
Matz, J.
Townley, R.
O'Brien, J.
Noga, O.
Champain, K.
Fox, H.
Thirlwell, J.
Della Cioppa, G.

Issue Date

2002

Volume

20

Issue

1

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Buhl, R.; Soler, M.; Matz, J.; Townley, R.; O'Brien, J.; Noga, O.; Champain, K.; Fox, H.; Thirlwell, J.; Della Cioppa, G. Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. European Respiratory Journal. 2002, JUL. 20(1):73-78.

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

Identifier

ISSN

0904-1850
0903-1936

EISSN